In an early Christmas gift to some, Chile and Mexico began vaccinations Thursday after granting emergency approval for the Pfizer / BioNTech vaccine. But in Brazil, where the death toll from Covid-19 is much higher, inoculation to save lives could be out of reach for months; the country’s Ministry of Health announced last week that vaccinations would begin in February 2021.
Because Brazil has a strong national vaccination history, he says there was a widespread expectation that Brazilians would have a regional advantage in the battle against the pandemic.
“Brazil has always been the leader in the implementation of new vaccines. We achieve high vaccine coverage, although it is a continental country with very different regions, such as São Paulo with a high population density and the Amazon, with huge distances. , (i) an indigenous population, ”he said.
“People expected the Brazilian vaccination program to start sooner,” he said. But “other countries in the Americas that were preparing are already starting vaccination and Brazil has lagged behind.”
With more than 7.4 million people diagnosed with Covid-19 in Brazil and new variants of the virus appearing abroad, there is little reason to think the pandemic is shrinking, a statement Bolsonaro repeatedly made this year. year, even as cases continued to rise in the country. Only the United States and India have reported more coronavirus infections than Brazil.
The Brazilian president also made headlines last week with an extravagant attempt to sow doubts about the possible side effects of the Pfizer vaccine. “If you become an alligator, that’s your problem,” he warned. “If she becomes Superman, or she shaves like a woman, or if a man’s voice gets high, I have nothing to do with it … or, worse, it interferes with people’s immune systems.” .
Pfizer did not respond to CNN’s request for comment.
Domingues believes the Brazilian federal government was not seen ready to use the Pfizer / BioNTech vaccine, after giving its support to a vaccine candidate from Oxford University and AstraZeneca, who have partnered with the foundation local Fiocruz. According to a statement released last week by the Ministry of Health, Brazil agreed to purchase more than 100 million doses of this vaccine, which is still under development.
Meanwhile, fears persist about the influence of politics in the process, after a year of bitter clashes between Bolsonaro and state governors over the country’s pandemic response.
The president has made no secret of his preference for the Oxford / AstraZeneca vaccine over the vaccine developed by Chinese manufacturer Sinovac Biotech, which is supported by the state of Sao Paulo and is developed locally with the Brazilian laboratory Butantan Institute.
ANVISA and the Brazilian Ministry of Health did not respond to requests for comment.
Reports provided by Tatiana Arias, Jennifer Z. Deaton, Natalie Gallon and Stefano Pozzebon.